Harnessing bio-photonics and Artificial Intelligence to unlock new possibilities in Alzheimer’s drug discovery.
iLoF is creating a pathway which promotes breakthroughs in Alzheimer's disease research. iLoF (short for Intelligent Lab on a Fiber) it is using machine-learning to develop an non-invasive way of screening patients for clinical trials, which will accelerate the development of new and personalised Alzheimer’s treatments and make them more economically viable.
“We all know the social tragedy behind Alzheimer’s – but the industry problem behind that is less visible. The [Wild Card] programme allowed us to study a whole industry at a deeper level and understand that in order to solve Alzheimer’s and enable a treatment, we first need precise, personalised, inexpensive tools that all stakeholders can apply. And because of that, suddenly, iLoF was born.”